Rare Cancers | NFCR Blog

Rare cancers are those that affect fewer than 40,000 people per year in the U.S.* For multiple reasons, there is a gap in research support for rare cancers, which can limit research progress. Learn more about NFCR’s genomic approach which aims to benefit ALL types of cancers.

Flu Virus Harnessed to Fight Pancreatic Cancer

Led by Dr. Gunnel Halldén of Queen Mary University in London, a…

Read more

Genomic Computational Mapping and Nutritional Supplementation in Multiple Myeloma

Multiple myeloma (MM) is a bone marrow cancer that affects plasma cells.…

Read more

Rare Disease Day: Sarcoma

Rare Disease Day falls on the last day of February each year,…

Read more

Protein Fueling Gallbladder Cancer Identified

With February being Gallbladder and Bile Duct Cancer Awareness Month, the National…

Read more

Pancreatic Cancer: What You Need to Know

We will today take an in-depth look at pancreatic cancer. The Who…

Read more

NFCR’s Genomics Newsroom: New genes linked to increased risk of ovarian and brain cancer

What is “genomics”? Cancer develops when genetic material (DNA) becomes damaged or…

Read more

New Treatment for Glioblastoma Multiforme Developed by NFCR Scientists

Dr. Web Cavenee and Dr. Paul B. Fisher discover a new pharmacological…

Read more